Induction of metabolism-dependent and -independent neutrophil apoptosis by clozapine.
about
Exploring off-targets and off-systems for adverse drug reactions via chemical-protein interactome--clozapine-induced agranulocytosis as a case studyFunctional characterization of the complement receptor type 1 and its circulating ligands in patients with schizophrenia.Late onset clozapine induced agranulocytosis.Clozapine metabolites protect dopaminergic neurons through inhibition of microglial NADPH oxidase.Genome-wide common and rare variant analysis provides novel insights into clozapine-associated neutropenia.Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine.
P2860
Induction of metabolism-dependent and -independent neutrophil apoptosis by clozapine.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Induction of metabolism-dependent and -independent neutrophil apoptosis by clozapine.
@ast
Induction of metabolism-dependent and -independent neutrophil apoptosis by clozapine.
@en
type
label
Induction of metabolism-dependent and -independent neutrophil apoptosis by clozapine.
@ast
Induction of metabolism-dependent and -independent neutrophil apoptosis by clozapine.
@en
prefLabel
Induction of metabolism-dependent and -independent neutrophil apoptosis by clozapine.
@ast
Induction of metabolism-dependent and -independent neutrophil apoptosis by clozapine.
@en
P2093
P1476
Induction of metabolism-dependent and -independent neutrophil apoptosis by clozapine.
@en
P2093
D J Naisbitt
D P Williams
J P Uetrecht
M Pirmohamed
P304
P577
2000-07-01T00:00:00Z